Invesque (IVQ) Competitors

ProMIS Neurosciences (TSE:PMN) and Invesque (TSE:IVQ) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability, valuation, community ranking and media sentiment.

Do insiders and institutionals hold more shares of PMN or IVQ?

2.2% of ProMIS Neurosciences shares are held by institutional investors. Comparatively, 27.1% of Invesque shares are held by institutional investors. 18.5% of ProMIS Neurosciences shares are held by company insiders. Comparatively, 31.0% of Invesque shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Is PMN or IVQ more profitable?

ProMIS Neurosciences has a net margin of 0.00% compared to Invesque's net margin of -32.66%. Invesque's return on equity of -23.17% beat ProMIS Neurosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ProMIS Neurosciences	N/A	-837.71%	-168.33%
Invesque	-32.66%	-23.17%	2.07%

Does the MarketBeat Community prefer PMN or IVQ?

ProMIS Neurosciences received 180 more outperform votes than Invesque when rated by MarketBeat users. Likewise, 70.86% of users gave ProMIS Neurosciences an outperform vote while only 60.71% of users gave Invesque an outperform vote.

Company	Underperform	Outperform
ProMIS Neurosciences	Outperform Votes 197 70.86%	Underperform Votes 81 29.14%
Invesque	Outperform Votes 17 60.71%	Underperform Votes 11 39.29%

Which has better earnings & valuation, PMN or IVQ?

ProMIS Neurosciences has higher earnings, but lower revenue than Invesque. ProMIS Neurosciences is trading at a lower price-to-earnings ratio than Invesque, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ProMIS Neurosciences	C$7.56 thousand	7,833.02	-C$20.93 million	-C$3.70	-1.86
Invesque	C$207.43 million	0.27	-C$58.69 million	-C$0.94	-1.06

Does the media refer more to PMN or IVQ?

In the previous week, Invesque had 3 more articles in the media than ProMIS Neurosciences. MarketBeat recorded 3 mentions for Invesque and 0 mentions for ProMIS Neurosciences. ProMIS Neurosciences' average media sentiment score of 0.00 beat Invesque's score of -0.13 indicating that ProMIS Neurosciences is being referred to more favorably in the media.

Company	Overall Sentiment
ProMIS Neurosciences	Neutral
Invesque	Neutral

Do analysts prefer PMN or IVQ?

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ProMIS Neurosciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Invesque	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Which has more risk & volatility, PMN or IVQ?

ProMIS Neurosciences has a beta of 1.15, meaning that its stock price is 15% more volatile than the S&P 500. Comparatively, Invesque has a beta of 0.98, meaning that its stock price is 2% less volatile than the S&P 500.

Summary

Invesque beats ProMIS Neurosciences on 8 of the 15 factors compared between the two stocks.